Globalization means that ideas, people, resources—and germs—now move unfettered from country to country with great speed. On balance, this is good news for the health of populations around the world. But globalization also raises ethical questions about the conduct of clinical research in developing countries, use of clinics abroad to train U.S. medical students, lack of essential medicines by many who need them, and migration of doctors from low-income countries to those with higher standards of living. July's contributors—many with international medical experience—take up these questions and more.
There are “push” factors such as poor working conditions, substandard facilities, unsafe conditions, and low income that discourage health professionals trained in Indian medical schools from staying in country.
A major contributor to the lack of medicines in developing countries is an intellectual property regime that allows proprietary drug companies with intellectual property monopolies to charge high prices and maximize profit.